Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Other Operating Expenses (2024 - 2025)

NeuroPace has reported Other Operating Expenses over the past 2 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $10.9 million for Q4 2025, up 9.9% from a year ago — trailing twelve months through Dec 2025 was $35.6 million (up 20.05% YoY), and the annual figure for FY2025 was $46.6 million, up 17.42%.
  • Other Operating Expenses for Q4 2025 was $10.9 million at NeuroPace, down from $12.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for NPCE hit a ceiling of $12.6 million in Q3 2025 and a floor of $9.8 million in Q2 2024.